Skip to Main Content

Paper Details

Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Diabetes Care
28
2010
50k, Diabetes, NFATC2, NFATC2 locus, SNP, Thiazolidinediones, cardiovascular, inflammatory, and metabolic genes, congestive heart failure, edema, participants, peripheral edema, protective allele, ramipril, rosiglitazone, rs6123045, single nucleotide polymorphisms (SNP) array, thiazolidinedione, thiazolidinedione-induced edema, type 2 diabetes
Author NameAffiliation
Swneke D BaileyMcGill University
  • 1 - 1

Datasets

Release 1.2